Comparison between Equitas Small Finance Bank IPO and Rossari Biotech IPO.
Equitas Small Finance Bank IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rossari Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Equitas Small Finance Bank IPO is up to ₹517.60 Cr whereas the issue size of the Rossari Biotech IPO is up to ₹496.25 Cr. The final issue price of Equitas Small Finance Bank IPO is ₹33.00 per share and of Rossari Biotech IPO is ₹425.00 per share.
| Equitas Small Finance Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹32.00 per share | ₹423.00 per share |
| Issue Price (Upper) | ₹33.00 per share | ₹425.00 per share |
| Issue Price (Final) | ₹33.00 per share | ₹425.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 450 shares | 35 shares |
| Fresh Issue Size | 8,48,48,484 shares | 11,76,470 shares |
| Fresh Issue Size (Amount) | up to ₹280.00 Cr | up to ₹50.00 Cr |
| OFS Issue Size | 7,20,00,000 shares | 1,05,00,000 shares |
| OFS Issue Size (Amount) | up to ₹237.60 Cr | up to ₹446.25 Cr |
| Issue Size Total | 15,68,48,484 shares | 1,16,76,470 shares |
| Issue Size Total (Amount) | up to ₹517.60 Cr | up to ₹496.25 Cr |
Equitas Small Finance Bank IPO opens on Oct 20, 2020, while Rossari Biotech IPO opens on Jul 13, 2020. The closing date of Equitas Small Finance Bank IPO and Rossari Biotech IPO is Oct 22, 2020, and Jul 15, 2020, respectively.
| Equitas Small Finance Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Oct 19, 2020 | Jul 10, 2020 |
| Issue Open | Oct 20, 2020 | Jul 13, 2020 |
| Issue Close | Oct 22, 2020 | Jul 15, 2020 |
| Basis Of Allotment (Tentative) | Oct 27, 2020 | Jul 20, 2020 |
| Initiation of Refunds (Tentative) | Oct 28, 2020 | Jul 21, 2020 |
| Credit of Share (Tentative) | Oct 29, 2020 | Jul 22, 2020 |
| Listing date (Tentative) | Nov 02, 2020 | Jul 23, 2020 |
| Anchor Lockin End date 1 | Nov 26, 2020 | Aug 19, 2020 |
| Anchor Lockin End date 2 | Jan 25, 2021 | Oct 18, 2020 |
Equitas Small Finance Bank IPO P/E ratio is , as compared to Rossari Biotech IPO P/E ratio of 33.81.
| Equitas Small Finance Bank IPO | Rossari Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 95.06 | |||||
| Promoter Shareholding (Post-Issue) | 73 | |||||
| P/E Ratio | 33.81 | |||||
| Market Cap | ₹3756.23 Cr. | ₹2207.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Equitas Small Finance Bank IPO Retail Individual Investors (RII) are offered 4,93,81,819 shares while in Rossari Biotech IPO retail investors are offered 4,93,81,819 shares. Qualified Institutional Buyers (QIB) are offered 2,82,18,182 shares in Equitas Small Finance Bank IPO and 23,35,294 shares in Rossari Biotech IPO.
| Equitas Small Finance Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,23,27,271 shares | 35,02,940 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 2,82,18,182 shares | 23,35,294 shares |
| NII | 2,11,63,637 shares | 17,51,471 shares |
| RII | 4,93,81,819 shares | 40,86,765 shares |
| Employee | 3,03,030 shares | |
| Others | ||
| Total | 15,68,48,484 shares | 1,16,76,470 shares |
Equitas Small Finance Bank IPO subscribed 1.95x in total, whereas Rossari Biotech IPO subscribed 79.37x.
| Equitas Small Finance Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| QIB (times) | 3.91x | 85.26x |
| NII (times) | 0.22x | 239.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.08x | 7.23x |
| Employee (times) | 1.84x | |
| Other (times) | 0.42x | |
| Total (times) | 1.95x | 79.37x |
